Searched for
NOVO NORDISK STOCK PLUNGE AMID COMPETITION
Govt raises onion procurement price by 13% as buffer stock buying strugglesGovernment hikes onion procurement price by 13% to Rs 2,125/quintal, effective July 4, 2026, to boost buffer stock purchases amid a slow st...- Explained: Why Tesla shares crashed 7% to record worst single-day fall in 1 year despite record Q2 salesTesla shares plunged over 7% despite the EV maker reporting record second-quarter deliveries that beat Wall Street estimates. Analysts attr...
- Microsoft launches firm to help companies adopt AI with $2.5 billionMicrosoft has launched a new venture, Microsoft Frontier Company, backed by $2.5 billion, to guide businesses in selecting and integrating ...
- Medical device maker Zimmer Biomet to hire 500 employees in 3 years for tech centre in IndiaMedical device giant Zimmer Biomet is set to significantly expand its Indian footprint by hiring 500 professionals over three years for its...
- Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- Samsung, SK Hynix shares crash up to 14% as Kospi’s massive bloodbath enters day 2Samsung Electronics and SK Hynix shares plunged as much as 14% as South Korea’s Kospi extended its sharp selloff for a second day. The decl...
- Japanese stocks hit by biggest foreign weekly selloff since March as tech rally coolsForeign investors recorded their biggest weekly selloff in Japanese stocks since March, offloading ¥1.82 trillion worth of shares amid prof...
- Macro headwinds are behind us; largecaps poised to outperform: Prashant JainIndia's equity markets are poised for a positive turn as economic challenges recede, according to Prashant Jain. He highlights strong domes...
- Seoul stocks plunge 8% as Samsung, SK hynix shares tumbleSouth Korean stocks plunged nearly eight percent at close Thursday as tech giants Samsung and SK hynix tumbled on fears of slowing AI chip ...
- Paint stocks tumble up to 48% from their peaks. Is the worst over?Paint stocks have declined sharply from their 52-week highs, correcting between 10% and 48%, as investors turn cautious due to rising compe...
- Shutterstock shares crash 29% after Getty Images calls off $3.7 billion mergerShutterstock shares plunged nearly 30% after Getty Images scrapped its $3.7 billion merger following UK regulator objections. The Competiti...
- Waaree Energies shares crash 5%. Can this US ruling dent solar panel maker's image for long?Waaree Energies shares fell nearly 5% after a US Customs ruling triggered concerns over reputational impact despite the company’s clarifica...
- Toyota sales fall for fourth month in May as declines in China, US and Middle East weighToyota Motor Company experienced a 7.2% drop in global vehicle sales for May, reflecting a fourth straight month of downfall. This slump st...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- SpaceX shares eke out a gain to snap three day losing streakSpaceX shares rebounded Tuesday, halting a three-day slump that saw over $600 billion vanish from its valuation. The stock climbed signific...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Bombay HC cancels 'Duphachrit' trademark, rules it deceptively similar to Abbott's 'Dupha' familyThe Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
Load More
